Research

Scientists at FAU are conducting research into multidrug-resistant germs. Their research is to receive a total of nearly one million euros in funding from the Leibniz “Cooperative excellence” program.

Researchers at FAU hope to develop a new procedure aimed at gaining pure hydrogen from biological waste. The BMBF has approved approximately 3.2 million euros in funding for the project. 

Cholesterol plays a decisive role in the elasticity of cell membranes. Researchers at FAU have now discovered that cholesterol has a remarkable double role: It not only contributes to making the membrane thicker and more impenetrable, but surprisingly also softer.

Major success for Sandra Jeleazcov: She developed an app that paves the way for new approaches to patient communication. Using virtual reality, the application informs patients suffering from lupus about the rare immune disease.

Prof. Aldo R. Boccaccini, Chair of Materials Science (Biomaterials), Department of Materials Science and Engineering at FAU, has been elected Fellow of Biomaterials Science and Engineering (FBSE), the highest honor the global biomaterials community can bestow on outstanding biomaterials scientists, ...

Two researchers have been awarded a Consolidator Grant from the European Research Council. The ERC Consolidator Grant entails two million euros in funding over a funding period of five years.

Once again, FAU has successfully demonstrated its strength in innovation and research. In the current funding round, the University has succeeded in winning not one, but two more Humboldt professorships: Prof. Dr. Michaela Mahlberg and Prof. Dr. Eva Pils.

This year, the Federal President’s prize for technology and innovation has been awarded to a team from Erlangen. Prof. Dr. Michael Uder and his two team colleagues from Siemens Healthineers have been awarded the German Future Prize 2023.

The Highly Cited Researchers List of 2023 names the 7,127 most influential researchers across the globe. With a total of 336 researchers included in the list, Germany is ranked number 4.

Malaria is one of the most widespread and deadly infectious diseases worldwide. New compounds are continuously required due to the risk of malaria parasites becoming resistant to the medicines currently used. A team of researchers at FAU led by Prof. Dr. Svetlana B. Tsogoeva has now combined the anti-malaria drug artemisinin with coumarin, which, like artemisinin, is also found in plants, and developed an auto-fluorescent compound from both bioactive substances.